Differences between heart failure specialists and non‐specialists regarding heart failure drug implementation and up‐titration.

Differences between heart failure specialists and non-specialists regarding heart failure drug implementation and up-titration Following the 2021 heart failure (HF) European guidelines,[1] an extensive web-based international survey questioning more than 600 cardiologists about their perception of HF sequencing and titrating approach of therapy in HF with reduced ejection fraction (HFrEF) was published.[2] This study raises queries about the optimal sequencing approach and how to apply a simple algorithm for the cardiology community, keeping in mind that the therapeutic HF arsenal continues to increase and considering individual patients' particularities. Indeed, since HF prevalence is rising worldwide,[3] "HF specialists" cannot manage all HFrEF patients. [Extracted from the article]